399441 生物医药
交易中 12-16 14:18:36
资讯
新帖
简况
中国科学院院士陈润生：人工智能在生物医药、医学影像等领域展现出超凡实用价值
睿见Economy · 11:51
中国科学院院士陈润生：人工智能在生物医药、医学影像等领域展现出超凡实用价值
康斯特：国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业
证券之星 · 12-15 19:12
康斯特：国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业
12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 12-15 15:37
12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期
中金财经 · 12-15 07:37
派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期
派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元
智通财经 · 12-14 19:35
派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元
12月11日智飞生物创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 12-11
12月11日智飞生物创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
安科生物姚建平：“AI+生物医药”大有可为
睿见Economy · 12-11
安科生物姚建平：“AI+生物医药”大有可为
开放新高地 海南产业蜕变：生物医药领跑、南繁种业创新
21世纪经济报道 · 12-11
开放新高地 海南产业蜕变：生物医药领跑、南繁种业创新
港股生物医药股表现活跃！歌礼制药-B涨超20%，圣诺医药-B涨超13%
老虎资讯综合 · 12-09
港股生物医药股表现活跃！歌礼制药-B涨超20%，圣诺医药-B涨超13%
ADC与PD-1红海之外，宝济药业如何找到生物医药的“第二增长曲线”？
智通财经 · 12-05
ADC与PD-1红海之外，宝济药业如何找到生物医药的“第二增长曲线”？
港股开盘 | 恒指低开0.4%，科指低开0.41%！生物医药股普涨
老虎资讯综合 · 12-05
港股开盘 | 恒指低开0.4%，科指低开0.41%！生物医药股普涨
复拓知达“一次性使用肺结节三维标识定位标记物”入选《上海市生物医药“新优药械”产品目录》
人民财讯 · 12-04
复拓知达“一次性使用肺结节三维标识定位标记物”入选《上海市生物医药“新优药械”产品目录》
港股生物医药板块持续走低，泰格医药、君实生物跌超3%
每日经济新闻 · 12-02
港股生物医药板块持续走低，泰格医药、君实生物跌超3%
复星国际陈启宇：中国生物医药创新需走“创新+全球化”双轮驱动之路
经济参考网 · 11-28
复星国际陈启宇：中国生物医药创新需走“创新+全球化”双轮驱动之路
派格生物医药-B(02565)就申请建议实行H股全流通向中国证监会备案
智通财经 · 11-28
派格生物医药-B(02565)就申请建议实行H股全流通向中国证监会备案
派格生物医药-B(02565.HK)高开逾7%
每日经济新闻 · 11-27
派格生物医药-B(02565.HK)高开逾7%
派格生物医药-B(02565)：基石投资者自愿延长禁售期
智通财经 · 11-26
派格生物医药-B(02565)：基石投资者自愿延长禁售期
工信部等6部门：围绕高性能纤维、家电、电池、日化、生物医药、生物制造等消费品工业领域 建设一批中试验证平台
格隆汇APP · 11-26
工信部等6部门：围绕高性能纤维、家电、电池、日化、生物医药、生物制造等消费品工业领域 建设一批中试验证平台
董莉君：艾伯维愿积极参与山东生物医药生态建设
齐鲁晚报 · 11-26
董莉君：艾伯维愿积极参与山东生物医药生态建设
生物医药股悉数走强 荣昌生物(09995)涨6.65% 机构指医药行业近期震荡调整后估值已回落至相对低位
金吾财讯 · 11-26
生物医药股悉数走强 荣昌生物(09995)涨6.65% 机构指医药行业近期震荡调整后估值已回落至相对低位
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2142.05,"timestamp":1765865916000,"preClose":2164.8,"halted":0,"volume":279855654,"delay":0,"changeRate":-0.0105,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-22.75,"latestTime":"12-16 14:18:36","open":2166.13,"high":2174.59,"low":2138.35,"amount":9889000000,"amplitude":0.0167,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765868400000},"marketStatusCode":2,"adr":0,"adjPreClose":2164.8,"symbolType":"index","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2591677531","title":"中国科学院院士陈润生：人工智能在生物医药、医学影像等领域展现出超凡实用价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2591677531","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591677531?lang=zh_cn&edition=full","pubTime":"2025-12-16 11:51","pubTimestamp":1765857060,"startTime":"0","endTime":"0","summary":"专题：第十八届中国工业论坛\n 第十八届中国工业论坛于12月16日在北京举办，主题为“融合创新 工业当强”。中国科学院院士陈润生出席并演讲。\n 陈润生指出，人工智能本质是“脑”的数字孪生，以大模型为核心应用载体，凭借自然语言处理突破与多模态融合创新，在生物医药、医学影像等领域展现出超凡的实用价值。当前，人工智能正引发科技领域深刻变革，持续关注与应用人工智能，将为我们的生产、生活带来重大效益。\n\n 新浪声明：所有会议实录均为现场速记整理，未经演讲者审阅，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王翔","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-12-16/doc-inhayftm3351938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1189","399441","161726","02251","161631"],"gpt_icon":0},{"id":"2591664822","title":"康斯特：国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2591664822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591664822?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:12","pubTimestamp":1765797139,"startTime":"0","endTime":"0","summary":"证券之星消息，康斯特(300445)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问美国太空探索技术公司（SpaceX）是不是贵司的客户？公司为其提供哪些产品呢？康斯特回复：您好，非常感谢您的关注与支持。公司已能为全球产业用户提供高效的压力/温湿度/过程信号校准测试仪表设备，应用区域分布广泛且不依赖单一客户，国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业，包括太空探索等行业客户订单金额较小，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500026124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300445","161726","BK0225","399441","BK0028"],"gpt_icon":0},{"id":"2591153066","title":"12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591153066","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591153066?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:37","pubTimestamp":1765784229,"startTime":"0","endTime":"0","summary":"证券之星消息，12月15日上海莱士创60日新低，收盘报6.34元，当日跌1.55%，换手率0.52%，成交量34.48万手，成交额2.2亿元。重仓上海莱士的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4037，较上一交易日上涨0.45%，近一年下跌1.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500013020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0239","161726","BK0196","002252","BK0028","399441"],"gpt_icon":0},{"id":"2591660659","title":"派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660659","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660659?lang=zh_cn&edition=full","pubTime":"2025-12-15 07:37","pubTimestamp":1765755421,"startTime":"0","endTime":"0","summary":"格隆汇12月15日丨派格生物医药-B(02565.HK)发布公告，近日，公司接获基石投资者的通知，据此，基石投资者同意自原禁售期(经第一次禁售延长予以延长)届满日期起至2026年4月30日不会以任何方式减持任何相关H股(“第二次禁售延长”)。公司认为，第二次禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。基石投资者亦将持续审阅公司业绩，且或会基于实时发展及所实现的里程碑，考虑进一步延长禁售期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251215/31864713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02565","399441","BK1161","161726"],"gpt_icon":0},{"id":"2591663104","title":"派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663104","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663104?lang=zh_cn&edition=full","pubTime":"2025-12-14 19:35","pubTimestamp":1765712100,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，于2025年12月12日，本公司与联席配售代理订立配售协议，据此，本公司已有条件同意透过联席配售代理按尽力基准以每股配售股份58.41港元的价格向不少于六名承配人配售合共513.6万股配售股份，该等配售股份将由本公司根据一般授权按配售协议所载条款及条件发行。假设所有配售股份获悉数配售，配售的估计所得款项总额及所得款项净额将分别为约3亿港元及约2.96亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","399441","BK1161","161726"],"gpt_icon":0},{"id":"2590600445","title":"12月11日智飞生物创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590600445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590600445?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:37","pubTimestamp":1765438643,"startTime":"0","endTime":"0","summary":"证券之星消息，12月11日智飞生物创60日新低，收盘报19.38元，当日跌2.22%，换手率0.99%，成交量13.98万手，成交额2.73亿元。重仓智飞生物的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4034，较上一交易日上涨0.52%，近一年下跌0.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","161726","LU1064131003.USD","LU2580892862.HKD","BK0046","BK0196","300122","399441","LU1064130708.USD","LU1328615791.USD","BK0077","BK0188","BK0239","LU2580892789.USD"],"gpt_icon":0},{"id":"2590955777","title":"安科生物姚建平：“AI+生物医药”大有可为","url":"https://stock-news.laohu8.com/highlight/detail?id=2590955777","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590955777?lang=zh_cn&edition=full","pubTime":"2025-12-11 09:39","pubTimestamp":1765417140,"startTime":"0","endTime":"0","summary":" “2025中国企业竞争力年会”于12月9日至10日在北京举行。安徽安科生物工程（集团）股份有限公司执行总裁姚建平在演讲中表示，“AI+生物医药”完全可以结合。姚建平透露，近期合肥多家量子领域龙头企业均主动与他对接，探讨“AI+生物医药”的合作可能，这充分说明跨领域融合已成为产业共识。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-12-11/doc-inhakwan8050860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0042","300009","BK0060","161726","BK0239","399441","BK0070"],"gpt_icon":0},{"id":"2590559597","title":"开放新高地 海南产业蜕变：生物医药领跑、南繁种业创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2590559597","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590559597?lang=zh_cn&edition=full","pubTime":"2025-12-11 07:00","pubTimestamp":1765407600,"startTime":"0","endTime":"0","summary":"生物医药产业领跑 近年来，海南自贸港在政策引导下，不断扩大开放程度，产业集群迸发活力。生物医药产业是海南省战略性新兴产业，也是海口高新区的领跑产业。向种图强，向海突破 除了生物医药产业，南繁种业和深海科技也是海南的一块“金字招牌”。业内人士指出，崖州湾国家实验室首单数据知识产权的成功登记，填补了海南省在数据知识产权登记","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-11/doc-inhakmnt8493069.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-11/doc-inhakmnt8493069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","161726"],"gpt_icon":0},{"id":"1166068199","title":"港股生物医药股表现活跃！歌礼制药-B涨超20%，圣诺医药-B涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166068199","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166068199?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:02","pubTimestamp":1765245754,"startTime":"0","endTime":"0","summary":"12月9日，港股$生物(000504)$医药股表现活跃，$歌礼制药-B(01672)$涨超20%，$圣诺医药-B(02257)$涨超13%，$昭衍新药(06127)$涨超10%，$药明合联(02268)$涨超4%，$药明生物(02269)$、$药明康德(02359)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"eb673bcce88aebafcbc37fb491eb2df2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","02257","BK1191","399441","BK1515","BK1574","01477","161726","BK1161"],"gpt_icon":0},{"id":"2589865213","title":"ADC与PD-1红海之外，宝济药业如何找到生物医药的“第二增长曲线”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2589865213","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589865213?lang=zh_cn&edition=full","pubTime":"2025-12-05 13:33","pubTimestamp":1764912788,"startTime":"0","endTime":"0","summary":"而在ADC、PD-1等热门靶点赛道数百家企业拥挤厮杀，从临床入组速度到未来的市场定价无不白热化的竞争中，上海宝济药业股份有限公司选择了一条截然不同的差异化战略路径。与传统疗法相比，KJ103的革命性优势则在于其“快”。目前，其领先地位和临床价值已获得监管机构的高度认可。对于KJ017而言，其市场空间并不取决于自身的销量，而是与整个千亿级生物药市场的增长深度绑定，其商业模式堪称典型的“卖水人”逻辑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PD","LU1169590202.USD","ADC","02659","BK4231","161726","BK4023","BK4080","LU1169589451.USD","399441"],"gpt_icon":1},{"id":"1133613786","title":"港股开盘 | 恒指低开0.4%，科指低开0.41%！生物医药股普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1133613786","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133613786?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:20","pubTimestamp":1764897630,"startTime":"0","endTime":"0","summary":"12月5日，港股开盘，恒指开跌0.4%，科指开跌0.41%。科网股多数走低，腾讯、网易跌幅靠前；生物医药股普涨，荃信生物-B涨近6%，亚盛医药-B涨超3%；趣致集团涨近6%，与迪拜达成战略协作，推进HOLOX项目","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHImain","HSTECH","HSImain","161726","513600","02833","HHImain","YANG","BK4614","399441","MCHmain","HSI"],"gpt_icon":0},{"id":"2588411886","title":"复拓知达“一次性使用肺结节三维标识定位标记物”入选《上海市生物医药“新优药械”产品目录》","url":"https://stock-news.laohu8.com/highlight/detail?id=2588411886","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588411886?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:38","pubTimestamp":1764848327,"startTime":"0","endTime":"0","summary":"人民财讯12月4日电，近日，上海市科学技术委员会对《上海市生物医药“新优药械”产品目录》（第七批）进行公示，24款“新优药械”列入目录。由复星诊疗科技旗下企业复拓知达自主研发的一次性使用肺结节三维标识定位标记物入选。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512043582841753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["161726","399441"],"gpt_icon":0},{"id":"2588608692","title":"港股生物医药板块持续走低，泰格医药、君实生物跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588608692","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588608692?lang=zh_cn&edition=full","pubTime":"2025-12-02 11:49","pubTimestamp":1764647365,"startTime":"0","endTime":"0","summary":"港股生物医药板块持续走低，泰格医药、君实生物跌超3%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512023580206556.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512023580206556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK0174","399441","BK1583","688180","BK1576","BK0216","BK1515","BK1161","01877","LU1146622755.USD","161726","LU1820825898.SGD","BK0028","BK0077","300347","03347","BK0239"],"gpt_icon":0},{"id":"2586780718","title":"复星国际陈启宇：中国生物医药创新需走“创新+全球化”双轮驱动之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2586780718","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586780718?lang=zh_cn&edition=full","pubTime":"2025-11-28 21:52","pubTimestamp":1764337920,"startTime":"0","endTime":"0","summary":"11月24-26日，主题为“结构性拐点”的2025第十七届中国医药企业家科学家投资家大会（简称“启思会”）暨海淀医药健康全产业链创新峰会在北京召开。复星国际（00656.HK）执行董事兼联席首席 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251128/c672834666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["399441","161726"],"gpt_icon":0},{"id":"2586202061","title":"派格生物医药-B(02565)就申请建议实行H股全流通向中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2586202061","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586202061?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:45","pubTimestamp":1764319505,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，本公司已于2025年11月28日就按一比一的基准将本公司20名股东持有的合共1.02亿股未上市股份转换为本公司H股(占本公司于本公告日期已发行股份总数约26.35%)而向中国证监会提交申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","02565","BK1161","161726"],"gpt_icon":0},{"id":"2586297590","title":"派格生物医药-B(02565.HK)高开逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586297590","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586297590?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:44","pubTimestamp":1764207862,"startTime":"0","endTime":"0","summary":"每经AI快讯，派格生物医药-B(02565.HK)高开逾7%，截至发稿，涨7.03%，报70港元，成交额77万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511273576346796.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511273576346796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02565","399441","BK1161","161726"],"gpt_icon":0},{"id":"2586547062","title":"派格生物医药-B(02565)：基石投资者自愿延长禁售期","url":"https://stock-news.laohu8.com/highlight/detail?id=2586547062","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586547062?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:40","pubTimestamp":1764160855,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，近日，本公司接获益泽康瑞医药(香港)有限公司(基石投资者)的通知，基石投资者同意自原禁售期届满日期起至2025年12月31日不会以任何方式减持任何相关H股(禁售延长)。本公司认为，禁售期延长表明基石投资者基于本公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对本公司的未来前景充满信心。基石投资者亦将持续审阅本公司业绩，且或会基于实时发展及所实现的里程碑，考虑进一步延长禁售期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","02565","BK1161","161726"],"gpt_icon":0},{"id":"2586359522","title":"工信部等6部门：围绕高性能纤维、家电、电池、日化、生物医药、生物制造等消费品工业领域 建设一批中试验证平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2586359522","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586359522?lang=zh_cn&edition=full","pubTime":"2025-11-26 14:32","pubTimestamp":1764138720,"startTime":"0","endTime":"0","summary":"格隆汇11月26日丨工业和信息化部等六部门印发《关于增强消费品供需适配性进一步促进消费的实施方案》提出，加快布局新领域新赛道。聚焦智能网联新能源汽车、智能家居、消费电子、现代纺织、食品、绿色建材等重点行业，开展双百典型创新应用专项活动，打造百个标志性产品、百家创新企业和一批可体验可推广的新产品首用场景样板。围绕高性能纤维、绿色印染、造纸、家电、电池、日化、生物医药、生物制造等消费品工业领域，建设一批中试验证平台。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-11-26/doc-infytiza2097775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161726","399441","159796"],"gpt_icon":0},{"id":"2586287851","title":"董莉君：艾伯维愿积极参与山东生物医药生态建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2586287851","media":"齐鲁晚报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586287851?lang=zh_cn&edition=full","pubTime":"2025-11-26 12:06","pubTimestamp":1764129960,"startTime":"0","endTime":"0","summary":"齐鲁晚报.齐鲁壹点记者李殷婷“外资如桥，一端连接中国式现代化的澎湃脉搏，一端贯通全球创新资源的浩瀚海洋。艾伯维愿继续发挥我们在研发、临床与国际合作方面的优势，积极参与山东生物医 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/usstock/20251126/c672746372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["161726","399441"],"gpt_icon":0},{"id":"2586289514","title":"生物医药股悉数走强 荣昌生物(09995)涨6.65% 机构指医药行业近期震荡调整后估值已回落至相对低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2586289514","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586289514?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:08","pubTimestamp":1764122938,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股悉数走强，截至发稿，荣昌生物 涨6.65%，复宏汉霖涨4.85%，君实生物涨4.43%，康诺亚-B涨4.01%，康方生物涨3.62%，泰格医药涨3.33%，诺诚健华涨3.14%。总体上，2026年预计政策端仍将驱动医药行业腾笼换鸟、创新升级。该机构看好2026年医药行业投资机会，近期震荡调整后估值已回落至相对低位，有望在2026年重启升势，投资思路上寻找医药硬科技和细分赛道α，推荐关注创新药、创新器械、医疗AI方向，关注医药消费复苏及独立第三方ICL。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970350","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1720050803.USD","09969","688331","LU2399975544.HKD","01877","LU0348783233.USD","03347","BK1161","LU0348767384.USD","02162","LU2476274720.SGD","LU2328871848.SGD","LU0540923850.HKD","LU0348825331.USD","BK1576","LU0348827113.USD","09926","09995","LU0417516571.SGD","LU1064130708.USD","BK1587","02696","LU0417516738.SGD","161726","BK1583","LU1064131003.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1961090484.USD","LU0348766576.USD","IE00BPRC5H50.USD","LU2148510915.USD","LU2778985437.USD","399441","BK1515","LU0348784397.USD","LU0634319403.HKD","LU2488822045.USD","LU1794554557.SGD","BK1141","BK1574","LU0348735423.USD","LU0561508036.HKD","HK0000165453.HKD","LU0417516902.SGD","LU1969619763.USD","LU2476274308.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765865920450,"stockEarnings":[{"period":"1week","weight":-0.0142},{"period":"1month","weight":-0.0794},{"period":"3month","weight":-0.1525},{"period":"6month","weight":0.0638},{"period":"1year","weight":-0.0075},{"period":"ytd","weight":0.0614}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}